<DOC>
	<DOCNO>NCT01798576</DOCNO>
	<brief_summary>This prospective , national , multicenter , observational study evaluate routine clinical practice efficacy safety re-treatment Pegasys ( peginterferon alfa-2a ) plus ribavirin regimen contain direct-acting antiviral participant chronic hepatitis C fail previous treatment . Participants follow duration treatment ( 24 , 48 72 week ) 24 week follow-up .</brief_summary>
	<brief_title>An Observational Study Pegasys ( Peginterferon Alfa-2a ) Plus Ribavirin Based Regimens Patients With Chronic Hepatitis C With Previous Treatment Failure</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Peginterferon alfa-2a</mesh_term>
	<criteria>Adult participant , &gt; /= 18 year age Participants chronic hepatitis C previously treat pegylated interferon , standard interferon , ribavirin No contraindication pegylated interferon ribavirin therapy treatment regimen contain DAAs detailed local label Treatment line summary Product Characteristics/local label Pegasys/ribavirin DAAs , particular : Positive serum hepatitis C virus ( HCV ) ribonucleic acid ( RNA ) Fertile male females receive ribavirin must use two form contraception treatment Pegasys/ribavirin 6 month posttreatment No coinfection hepatitis B human immunodeficiency virus ( HIV ) History evidence medical condition associate chronic liver disease chronic hepatitis C History neurological disease History severe psychiatric disease Decompensated diabetes History immunologically mediate disease History severe cardiac disease History evidence severe chronic pulmonary disease Inadequate hematologic function Pregnant breastfeed woman Male partner pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>